Skip to content

Clinical application of ERAS concept combined with robot-assisted precision osteotomy in knee joint arthroplasty

Clinical application of rapid rehabilitation concept combined with robot-assisted precision osteotomy in knee replacement

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086729
Enrollment
Unknown
Registered
2024-07-09
Start date
2023-07-05
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Robot-assisted total knee arthroplasty group (A group):ERAS combined with robot-assisted precision osteotomies
Traditional total knee arthroplasty group (B group):ERAS combined with conventional total knee arthroplasty

Sponsors

Panzhihua Municipal Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Meet the American College of Rheumatology diagnostic criteria for severe osteoarthritis of the knee; ? Patients who have all received strict conservative treatment that has been ineffective; ? Undergoing unilateral TKA surgery for the first time; ?Patients and their families agreed to the surgery, were informed about the study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Body mass index (BMI) >35kg/m^2; 2) Patients with heart, lung and other vital organ failure; 3) Abnormal liver and kidney function; 4) Patients with diabetes mellitus with poorly controlled blood levels and risk of infection as judged by the study; 5) Comorbid disorders of consciousness or mental illness; 6) History of open knee surgery; 7) have neuromuscular dysfunction affecting the lower limbs; 8) patients with severe coagulation disorders 9) Combination of serious medical or surgical illness or physical weakness that prevents the patient from tolerating surgery; 10) severe instability and incurable TKA with ligamentous retention; incurable; 11) Active foci of infection in the body (systemic or localised lesions) Active foci of infection in the body (systemic or localised lesions); 12) severe osteoporosis and metabolic disease radiomas around the knee joint; severe osteoporosis and metabolic disease radiomas around the knee joint; severe osteoporosis and metabolic disease radiomas around the knee joint; severe osteoporosis and metabolic disease radiomas around the knee joint; 13) Women who are planning to have a family, are breastfeeding, or are pregnant during the entire clinical study period; 14) Participation in another clinical trial within 3 months; 15) Participants who, in the opinion of the investigator, are unsuitable for other reasons.

Design outcomes

Primary

MeasureTime frame
Imaging score (FFC, FTC, LFC, LTC, HKA);

Secondary

MeasureTime frame
length of incision;time of operation;Osteotomy time;Perioperative blood loss;Perioperative complications;ROM;KSS score;VAS score;WOMAC score;the satisfaction of patients;

Countries

China

Contacts

Public ContactYuping Lan

Panzhihua Municipal Central Hospital

Lanyuping@163.com+86 180 9630 8666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026